REVIEW MetALD: Does it require a different therapeutic option? Marek GW & Harmeet Malhi #LiverTwitter tinyurl.com/56ftmxvy

Now out in CGH Pre-operative collaboration sets patients with #cirrhosis up for success sciencedirect.com/science/articl… Congratulations to Bachir Ghandour and 🧠Nadim Mahmud 🧠 from @PennGIHep

A study by our group shows high discrepancy between FIB-4 and VCTE! Would this frustrate PCPs? The study was led by Madeline Chang who is a high school student who took it from A to Z Alina Allen Maja Thiele Naim Alkhouri Aleksander Krag #livertiwtter CGH

Good morning from #Tx. Hurricane #Beryl Sheltering in place. No clinics. No electricity

Our new data showing the impact of MASLD on the US adult population. Advanced fibrosis in 8% of American adults and cirrhosis in 1.1%. Big implications for healthcare. Echosens Madrigal Pharmaceuticals Novo Nordisk US Medical Eric Topol Fibronostics akerotx Mazen Noureddin, MD, MHSc bmcgastroenterol.biomedcentral.com/counter/pdf/10…

🔥Would Love to share our thoughts on how to RX Resmetirom Naim Alkhouri Mary Rinella Rohit Loomba VCU Stravitz-Sanyal Institute for Liver Disease Meena Bansal #livertwitter Michael Charlton MD, FRCP Naga Chalasani Alina Allen CGH AASLD EASLnews Expert Panel Recommendations: Practical Clinical Applications for

With a Key figure on how to RX Rezdiffra #livertwitter

Colleagues, TLM registration for AASLD members opens tomorrow! Renew your membership to stay connected with hepatology leaders around the world, and best-in-class member benefits. my.aasld.org/renew

Thanks to EASLnews for the invite👇🏼 to chat about exciting MOA and durgs in #MASH and #obesity with outstanding European 🌎colleagues .pls join us #livertwitter Naim Alkhouri Ramy Younes, MD, PhD Aleksander Krag AASLD Altimmune, Inc. Shaheen Tomah, MD Merck Novo Nordisk Journal of Hepatology

Interesting read ! #livertwitter #GItwitter #Science #weightloss Weight loss drugs without the nausea? Mouse study suggests it may be possible | Science | AAAS science.org/content/articl…

Let's take a moment and revisit this very recent paper, "Monitoring Resmetirom in Patients with MASH/NASH" by Mazen Noureddin, MD, MHSc, Michael Charlton MD, FRCP, Stephen A. Harrison, Meena Bansal, Naim Alkhouri, Rohit Loomba, Arun J. Sanyal, and Maru Rinella MD. Open Access: Published: July 20, 2024: DOI:

Thank you Healio Gastroenterology for the invite. Led by Maru Rinella MD and having friends Michael Charlton MD, FRCP Naim Alkhouri Rohit Loomba Arun J. Sanyal Meena Bansal we hope this paper CGH is helpful #livertiwtter

Very exciting news for Arizona Liver Health . Hope to become the place for hepatic impairment trials and research imaging:) Mazen Noureddin, MD, MHSc Amreen Dinani Alina Allen Madrigal Pharmaceuticals akerotx ProSciento, Inc. Fortrea Boehringer Ingelheim Eli Lilly and Company VCU Stravitz-Sanyal Institute for Liver Disease Rohit Loomba

Study Identifies Most Accurate Noninvasive Method for Diagnosing MASH physiciansweekly.com/study-identifi… #livertwitter Naim Alkhouri Jörn Schattenberg Journal of Hepatology Echosens

In people with metabolic syndrome, drinking moderate amounts of alcohol does not only favor advanced liver disease, but also increases CANCER-RELATED MORTALITY. Close cancer surveillance is recommended in this population. t.ly/O42u0 Juan Pablo (JP) Arab, MD  Mazen Noureddin, MD, MHSc

This is chilling. Global Burden of alcohol-associated cirrhosis & cancer in young and middle-aged adults. Europe, we have a problem. And it's not small. 🙏Thanks for the data Mazen Noureddin, MD, MHSc CGH 🔗cghjournal.org/article/S1542-… #LiverTwitter

I am officially Pescatarian Since April!! Shira zelber sagi showed this in MASLD Naim Alkhouri Jörn Schattenberg V. Wendy Setiawan #livertwitter Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident